Feb. 26 at 4:50 PM
$AMBC Octave Specialty Group, Inc. (OSG) Q4 2025 Earnings Call February 24, 2026
For our Insurance Distribution segment, we are expecting organic revenue growth of at least 20% and adjusted EBITDA of approximately
$40 million for the full year 2026. For our Specialty Insurance segment, which includes Everspan, we expect gross written premiums of around
$410 million and adjusted EBITDA of approximately
$7.5 million for the full year 2026. Corporate adjusted expenses are expected to be below
$30 million for the year. And on a consolidated basis, we expect to generate adjusted net income of around
$0.50 per share for 2026.
https://seekingalpha.com/article/4874087-octave-specialty-group-inc-osg-q4-2025-earnings-call-transcript
One catalyst for this performance is the official launch of Hammurabi, our proprietary AI platform built specifically around the medical stop-loss business.
We are also actively utilizing and developing data and AI tools across our platform, which we believe will help us to rapidly scale and differentiate our business model into the future.